Chris Cuvelier's Insider Trades & SAST Disclosures

Chris Cuvelier's most recent trade in Arcadia Biosciences Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 17, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Arcadia Biosciences Inc
Chris Cuvelier Chief Growth Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2021 100,000 100,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades